We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

One Year Later: CRISPR Success in Duchenne Muscular Dystrophy Model

News   Feb 19, 2019 | Original story from Duke University

 
One Year Later: CRISPR Success in Duchenne Muscular Dystrophy Model

These images highlight the stark contrast between mouse models of untreated Duchenne muscular dystrophy (left) and those treated with a CRISPR-based genetic therapy after one year (right). On the right, green indicates a higher level of dystrophin gene expression. The dark spots in the inset show T cells from these mice responding to the bacterial Cas9 protein, indicating the presence of an immune response to the therapy. Credit: Charles Gersbach, Duke University

 
 
Advertisement
 

RELATED ARTICLES

Early Detection of Shade Avoidance Syndrome in Plants

News

Researchers have used Raman spectroscopy for the early detection of shade avoidance syndrome in plants, which can help farmers to improve plant health monitoring and lead to improved crop yield.

READ MORE

New Functions in the Gene That Causes Machado-Joseph Disease

News

UB researchers have identified new functions in the ataxin 3 gene (ATXN3) –which causes Machado-Joseph disease, the most common type of ataxia– in the development of retina photoreceptors.

READ MORE

Space Travel Can Adversely Impact Energy Production in a Cell

News

Studies reveal that the mitochondria can be made dysfunctional due to changes in gravity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE